seekingalpha.com · Oct 2, 2025
DIAX: Merger On The Table, The Discount To NAV Could Shrink
Nuveen Dow 30 Dynamic Overwrite Fund is set to merge with SPXX and BXMX, aiming for a larger, more efficient fund. DIAX has suffered from structural issues and persistent underperformance, trading at a significant discount to NAV compared to peers. The proposed merger is expected to benefit DIAX shareholders by potentially narrowing the current -9.6% discount to NAV and improving performance.


